Stock·NYSE·Industrials
Parker-Hannifin Corporation (PH)
- Market cap
- $121.29B
- P/E
- 33.66
- Dividend yield
- 0.79%
- Street target
- $1,212.00median of 26 analysts
- 52-week range
- $722.12 $1,099.94
The short version
Where PH stands today, in four lines, and what CleaRank Financial AI makes of it.
PH at a glance
Parker-Hannifin Corporation (PH): Buy, 70/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($948.56 and $984.37).
- Earnings PH beat estimates in 8 of its last 8 quarters, yet fell the next day after 2 of those beats.
- Insiders Insiders sold $65.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 33.7 against 34.0 for the Industrials sector: broadly in line with peers (-1%).
Figures as of October 16, 2026.
CleaRank Financial AI
Despite this, the company has demonstrated consistent earnings beats, with the latest quarter reporting EPS of $9.27 against an estimate of $8.27, a 12.09% surprise.
Revenue growth has been strong, projected at 14.00% for the next quarter and current year, signaling strong demand for its specialty industrial machinery. Wall Street analysts maintain a positive outlook, with a consensus 'Buy' rating and a median price target of $1212, suggesting a 26% upside potential. The significant insider selling, totaling $65.5 million, presents a notable risk that warrants close monitoring.
Only on CleaRank
Figures we compute ourselves from PH's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $961.75 is 2.3% below the 50-day simple moving average of $984.37.Price above its 200-day average ›
The price is 1.4% above the 200-day simple moving average of $948.56.50-day average above the 200-day ›
The 50-day average ($984.37) is 3.8% above the 200-day average ($948.56), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 63% of its 52-week range, between $722.12 and $1,099.94.
PH share price
Pick a period: each tab shows how far PH has moved over it, to the last close.
Today's trading
Where PH sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 33.66 is 1.0% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 5.64 is 41.0% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $3.6B on revenue of $21.5B, a net margin of 17.0%.Beat estimates in most recent reports ›
PH beat the EPS estimate in 8 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 0.79%, or $7.60 a share a year.
Key statistics
The headline figures for PH.
As of October 16, 2026, PH trades at $961.75, with a market value of $121.29B, a P/E ratio of 33.66 and a dividend yield of 0.79%.
What the numbers say
CleaRank Financial AI's reading of PH's valuation, growth and risks.
Parker-Hannifin Corporation exhibits strong profitability with a net profit margin of 16.97% and a return on equity of 25.08%, significantly outperforming the sector median ROE of 17.8%.
Its price-to-sales ratio stands at 5.64, which is higher than the sector median of 4.0, indicating a premium valuation relative to its sales. The P/E ratio of 33.66 is in line with the sector median of 34, suggesting that the market is valuing its earnings similarly to its peers. The company's debt-to-equity ratio is 0.57, which is consistent with the sector average, indicating a manageable debt load. Projected revenue growth of 14.00% for the next year and 11.2% for the year after that, coupled with strong historical earnings beats, supports the current valuation. However, the significant insider selling activity warrants attention as a potential counterpoint to the fundamental strength.
PH against the Industrials sector
How PH compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-1% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 5, 2025, PH has gained 56.0% against a gain of 23.7% for XLI.
Performance against XLI
PH and the Industrials sector fund over the same days.
Revenue and earnings
How much PH sells, and how much of it becomes profit.
Revenue growth: Revenue grew 8.3% in FY2026 to $21.5B, from $19.9B a year earlier.
Profit margin: The net margin was 17.0% in FY2026, down from 17.8% the year before.
Profitable: PH earned $3.6B in FY2026.
Earnings reality check
Did PH beat what analysts expected, and how did the stock react?
Earnings record: PH beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 2 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 6, 2026after close | $8.27 | $9.27 | +12.09% | +0.38% | -1.02% |
| Apr 30, 2026after close | $7.83 | $8.17 | +4.34% | -2.99% | -2.48% |
| Jan 29, 2026after close | $7.17 | $7.65 | +6.69% | -1.32% | +2.03% |
| Nov 6, 2025after close | $6.62 | $7.22 | +9.06% | +1.18% | +0.93% |
| Aug 7, 2025after close | $7.08 | $7.69 | +8.62% | +0.33% | +2.75% |
| May 1, 2025after close | $6.72 | $6.94 | +3.27% | +1.46% | +5.14% |
| Jan 30, 2025after close | $6.23 | $6.53 | +4.82% | +0.45% | -1.75% |
| Oct 31, 2024after close | $6.14 | $6.20 | +0.98% | +0.15% | +8.78% |
As of October 16, 2026, PH has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 2 of those beats; its latest report, on August 6, 2026, came in 12.09% above the estimate and the stock moved +0.38% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 49.1, in neutral territory.RSI above 50 ›
An RSI of 49.1 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of PH
The score, the reasoning behind it, and what could move the price next.
Parker-Hannifin Corporation's stock is currently trading below its 50-day SMA ($984.37) and its 20-day EMA ($962.04), suggesting downward pressure in the short term.
The price is above its 200-day SMA ($948.56), indicating a longer-term bullish trend remains intact. The 14-day RSI is at 49.08, reflecting neutral momentum, neither overbought nor oversold. Volume has been above average recently, with the latest volume at 561,600 compared to an average of 444,930, a 26.2% increase. Key support levels are around the 200-day SMA, while resistance is seen at the 50-day SMA and the 20-day EMA. The current technical setup suggests caution, with the price action needing to break above these short-term moving averages to signal a potential reversal.
Consistent Earnings Beats ›
Parker-Hannifin has a history of exceeding EPS estimates, with the latest quarter showing a 12.09% surprise, indicating strong operational execution and market demand.
Source: Earnings ReportsStrong Revenue Growth Projections ›
Analysts forecast 14.00% revenue growth for the next quarter and current year, signaling strong demand for the company's industrial machinery.
Source: Analyst Estimates
Heavy Insider Selling ›
Insiders have sold over $65.5 million worth of stock across recent filings, representing a significant heavy insider selling and a key risk factor.
Source: Insider TransactionsTrading Below Short-Term Moving Averages ›
The stock is currently below its 50-day SMA and 20-day EMA, indicating potential near-term technical weakness that could persist until a clear breakout occurs.
Source: Technical Analysis
- The stock is currently trading below its 50-day and 20-day moving averages, suggesting a potential for further short-term weakness until a clear upward trend re-establishes.
Technical indicators
Momentum and trend for PH, from its daily closes.
As of October 16, 2026, with PH at $961.75, its 14-day RSI is 49.1 (neutral territory), its 50-day simple moving average is $984.37 and its 200-day is $948.56.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What PH moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, PH's 1-year correlation of daily returns is +0.67 with S&P 500 (SPY), +0.58 with Nasdaq 100 (QQQ), +0.08 with Bitcoin (BTC) and +0.08 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
19 of 26 analysts rate it a buy or strong buy, 6 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $1,212.00 is 26.0% above the price.More buy ratings than three months ago ›
19 of 26 rate it a buy now, against 19 of 25 three months ago.
PH Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | JP Morgan | Maintains | Overweight |
| Sep 25, 2026 | Wells Fargo | Initiates | Equal-Weight |
| Aug 14, 2026 | Bernstein | Maintains | Outperform |
| Aug 11, 2026 | Evercore ISI Group | Maintains | Outperform |
| Aug 7, 2026 | UBS | Maintains | Buy |
| Aug 7, 2026 | Citigroup | Maintains | Buy |
As of October 16, 2026, 26 Wall Street analysts cover PH: 19 rate it a buy or strong buy, 6 a hold and 1 a sell or strong sell. Their 12-month price targets range from $680.00 to $1,358.00, with a median of $1,212.00, 26.0% above the price of $961.75.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
PH trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from PH's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much PH tends to move, against the market and on its own.
The long record
PH's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.18% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 51.6%, from February 2020 to March 2020, regained by September 2020.Most 1-year holds ended higher ›
80% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $89,701, against $42,525 in the S&P 500 (SPY).
PH Drawdowns & Recovery
As of October 16, 2026, PH's worst peak-to-trough fall over the last 10 years with dividends reinvested was -51.6% (February 2020 to March 2020); it regained that peak by September 2020, 6 months after the low, and 80% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into PH in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: PH beat the S&P 500 over this period: $89,701 against $42,525.
A $10,000 investment in PH in October 2016 would be worth about $89,701 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to PH, and which have not.
Strongest month, November: an average of +12.51%, up in 10 of 10 years.
Weakest month, March: an average of -5.44%, up in 2 of 10 years.
This month, October: has averaged +0.86%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, PH's strongest calendar month has been November (average +12.51%, up in 10 of 10 years) and its weakest March (average -5.44%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in PH, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in PH today could grow to about $27,479 by 2036 in the base case, with a 90th-percentile outcome near $99,519 and a 10th-percentile outcome around $7,587. The simulation models price only; at today's 0.79% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
PH Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $1,441 for PH by 2030 in the base case, from $962 today (1.5x over 4 years). The 10th-percentile path ends near $639. These are outcomes of a Monte Carlo simulation run on PH's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $708 | $1,064 | $1,598 | |
| 2028 | $662 | $1,177 | $2,093 | |
| 2029 | $644 | $1,302 | $2,636 | |
| 2030 | $639 | $1,441 | $3,252 | |
| 2031 | $642 | $1,594 | $3,961 |
Method: a lognormal simulation of PH's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
PH insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought PH shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, PH insiders reported 40 open-market sales worth $65.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Mark T. Czaja
Chief Technology Officer
|
Grant | 1.1K | - |
| Sep 8, 2026 | Laura K Thompson
Director
|
Sell | 160 | $153.4K |
| Aug 26, 2026 | Berend Bracht
Officer
|
Sell | 602 | $626.4K |
| Aug 26, 2026 | Berend Bracht
Officer
|
Option | 1.5K | $448.8K |
| Aug 18, 2026 | Patrick M. Scott
Officer
|
Grant | 95 | - |
| Aug 17, 2026 | Patrick M. Scott
Officer
|
Sell | 1.2K | $1.3M |
| Aug 14, 2026 | Andrew D. Ross
President
|
Sell | 5.5K | $5.8M |
| Aug 14, 2026 | Dinu John Parel
Chief Technology Officer
|
Sell | 4.5K | $4.7M |
| Aug 14, 2026 | Mark J Hart
Officer
|
Sell | 2.5K | $2.6M |
| Aug 14, 2026 | James R. Verrier
Director
|
Sell | 1.5K | $1.6M |
| Aug 14, 2026 | Berend Bracht
Officer
|
Sell | 700 | $738.5K |
| Aug 14, 2026 | Patrick M. Scott
Officer
|
Sell | 631 | $664.6K |
| Aug 14, 2026 | Jay Reidy
Officer
|
Sell | 300 | $316.7K |
| Aug 14, 2026 | Mark T. Czaja
Chief Technology Officer
|
Grant | 951 | - |
| Apr 22, 2026 | Rachid Bendali
Officer
|
Grant | 4.5K | - |
| Apr 22, 2026 | Berend Bracht
Officer
|
Grant | 4.5K | - |
| Apr 22, 2026 | Mark T. Czaja
Chief Technology Officer
|
Grant | 3.6K | - |
| Apr 22, 2026 | Thomas C. Gentile
Officer
|
Grant | 2.2K | - |
| Apr 22, 2026 | Mark J Hart
Officer
|
Grant | 4.5K | - |
| Apr 22, 2026 | Angela R Ives
Officer
|
Grant | 1.6K | - |
| Apr 22, 2026 | Matthew A. Jacobson
Officer
|
Grant | 1.4K | - |
| Apr 22, 2026 | Todd M. Leombruno
Chief Financial Officer
|
Grant | 8.3K | - |
| Apr 22, 2026 | Joseph R. Leonti
General Counsel
|
Grant | 4.5K | - |
| Apr 22, 2026 | Dinu John Parel
Officer
|
Grant | 4.5K | - |
| Apr 22, 2026 | Jennifer A Parmentier
Chief Executive Officer
|
Grant | 29.8K | - |
| Apr 22, 2026 | Jay Reidy
Officer
|
Grant | 3.7K | - |
| Apr 22, 2026 | Andrew D. Ross
President
|
Grant | 9.8K | - |
| Apr 22, 2026 | Patrick M. Scott
Officer
|
Grant | 3.8K | - |
| Feb 13, 2026 | Berend Bracht
Officer
|
Sell | 1.1K | $1.1M |
| Feb 13, 2026 | Rachid Bendali
Officer
|
Sell | 412 | $414.8K |
| Feb 13, 2026 | Rachid Bendali
Officer
|
Option | 830 | $245.7K |
| Feb 13, 2026 | Berend Bracht
Officer
|
Option | 2.9K | $852.7K |
| Feb 12, 2026 | Mark J Hart
Officer
|
Sell | 2.8K | $2.8M |
| Feb 12, 2026 | Thomas C. Gentile
Officer
|
Sell | 1.3K | $1.3M |
| Feb 12, 2026 | Patrick M. Scott
Officer
|
Sell | 833 | $818.9K |
| Feb 12, 2026 | Thomas C. Gentile
Officer
|
Option | 3.4K | $997.5K |
| Feb 12, 2026 | Mark J Hart
Officer
|
Option | 6.7K | $2.0M |
| Feb 12, 2026 | Patrick M. Scott
Officer
|
Option | 1.5K | $232.0K |
| Feb 11, 2026 | Jennifer A Parmentier
Chief Executive Officer
|
Sell | 4.7K | $4.7M |
| Feb 11, 2026 | Andrew D. Ross
President
|
Sell | 4.7K | $4.7M |
| Feb 11, 2026 | Todd M. Leombruno
Chief Financial Officer
|
Sell | 2.1K | $2.1M |
| Feb 11, 2026 | Todd M. Leombruno
Chief Financial Officer
|
Option | 4.0K | $641.5K |
| Feb 11, 2026 | Jennifer A Parmentier
Chief Executive Officer
|
Option | 10.2K | $2.1M |
| Feb 11, 2026 | Andrew D. Ross
President
|
Option | 10.2K | $2.1M |
| Feb 2, 2026 | Berend Bracht
Officer
|
Sell | 1.5K | $1.4M |
| Feb 2, 2026 | Dinu John Parel
Chief Technology Officer
|
Sell | 1.3K | $1.3M |
| Feb 2, 2026 | Matthew A. Jacobson
Officer
|
Sell | 564 | $535.8K |
| Feb 2, 2026 | Berend Bracht
Officer
|
Option | 3.4K | $997.5K |
| Feb 2, 2026 | Matthew A. Jacobson
Officer
|
Option | 970 | $161.5K |
| Feb 2, 2026 | Dinu John Parel
Chief Technology Officer
|
Option | 3.0K | $896.9K |
| Jan 30, 2026 | Thomas C. Gentile
Officer
|
Sell | 2.4K | $2.2M |
| Jan 30, 2026 | Angela R Ives
Officer
|
Sell | 1.1K | $1.0M |
| Jan 30, 2026 | Thomas C. Gentile
Officer
|
Option | 5.1K | $1.1M |
| Jan 30, 2026 | Angela R Ives
Officer
|
Option | 2.4K | $698.6K |
| Dec 11, 2025 | Andrew D. Ross
Chief Operating Officer
|
Sell | 2.5K | $2.2M |
| Dec 11, 2025 | Andrew D. Ross
Chief Operating Officer
|
Option | 6.7K | $2.0M |
| Dec 3, 2025 | Kevin A Lobo
Director
|
Grant | 2.0K | - |
| Nov 19, 2025 | Angela R Ives
Officer
|
Grant | 10 | - |
| Nov 14, 2025 | Angela R Ives
Officer
|
Grant | 10 | - |
| Nov 12, 2025 | Berend Bracht
Officer
|
Sell | 3.5K | $3.0M |
| Nov 12, 2025 | Rachid Bendali
Officer
|
Sell | 1.4K | $1.2M |
| Nov 12, 2025 | Jay Reidy
Officer
|
Sell | 391 | $337.7K |
| Nov 12, 2025 | Berend Bracht
Officer
|
Option | 3.4K | $997.5K |
| Nov 12, 2025 | Jay Reidy
Officer
|
Option | 1.1K | $319.7K |
| Oct 22, 2025 | James R. Verrier
Director
|
Grant | 258 | - |
| Oct 22, 2025 | Beth A Wozniak
Director
|
Grant | 258 | - |
| Sep 2, 2025 | James R. Verrier
Director
|
Sell | 1.5K | $1.1M |
| Aug 25, 2025 | Joseph R. Leonti
General Counsel
|
Sell | 4.6K | $3.5M |
| Aug 25, 2025 | Joseph R. Leonti
General Counsel
|
Option | 2.6K | $783.0K |
| Aug 12, 2025 | Dinu John Parel
Chief Technology Officer
|
Sell | 1.1K | $817.5K |
| Aug 8, 2025 | Andrew D. Ross
President
|
Sell | 4.4K | $3.2M |
| Aug 8, 2025 | Robert W Malone
Officer
|
Sell | 2.3K | $1.6M |
| Aug 8, 2025 | Mark J Hart
Officer
|
Sell | 2.3K | $1.6M |
| Aug 8, 2025 | Patrick M. Scott
Officer
|
Sell | 1.6K | $1.2M |
| Aug 8, 2025 | Thomas C. Gentile
Officer
|
Sell | 1.1K | $826.5K |
| Aug 8, 2025 | Angela R Ives
Officer
|
Sell | 810 | $589.2K |
| Aug 8, 2025 | Berend Bracht
Officer
|
Sell | 278 | $202.5K |
| Aug 8, 2025 | Angela R Ives
Officer
|
Option | 910 | $190.7K |
| Aug 8, 2025 | Patrick M. Scott
Officer
|
Option | 1.4K | $229.8K |
| May 28, 2025 | Joseph M Scaminace
Director
|
Sell | 958 | $639.5K |
| May 19, 2025 | Jay P. Reidy
Officer
|
Sell | 497 | $335.8K |
| May 19, 2025 | Jay P. Reidy
Officer
|
Option | 1.3K | $274.5K |
| May 2, 2025 | Jay P. Reidy
Officer
|
Sell | 150 | $93.1K |
| Apr 23, 2025 | Rachid Bendali
Officer
|
Grant | 3.5K | - |
| Apr 23, 2025 | Berend Bracht
Officer
|
Grant | 4.1K | - |
| Apr 23, 2025 | Mark T. Czaja
Chief Technology Officer
|
Grant | 3.3K | - |
| Apr 23, 2025 | Thomas C. Gentile
Officer
|
Grant | 2.1K | - |
| Apr 23, 2025 | Mark J Hart
Officer
|
Grant | 4.1K | - |
| Apr 23, 2025 | Angela R Ives
Officer
|
Grant | 1.4K | - |
| Apr 23, 2025 | Todd M. Leombruno
Chief Financial Officer
|
Grant | 7.6K | - |
| Apr 23, 2025 | Joseph R. Leonti
General Counsel
|
Grant | 4.1K | - |
| Apr 23, 2025 | Robert W Malone
Officer
|
Grant | 4.1K | - |
| Apr 23, 2025 | Dinu John Parel
Chief Technology Officer
|
Grant | 3.6K | - |
| Apr 23, 2025 | Jennifer A Parmentier
Chief Executive Officer
|
Grant | 24.7K | - |
| Apr 23, 2025 | Jay P. Reidy
Officer
|
Grant | 2.0K | - |
| Apr 23, 2025 | Andrew D. Ross
President
|
Grant | 7.9K | - |
| Apr 23, 2025 | Patrick M. Scott
President
|
Grant | 2.2K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.